Heidar Sharafi
Heidar Sharafi
Middle East Liver Disease (MELD) Center
Verified email at meldcenter.com
Title
Cited by
Cited by
Year
Next Steps Toward Eradication of Hepatitis C in the Era of Direct Acting Antivirals
K Hesamizadeh, H Sharafi, MS Rezaee-Zavareh, B Behnava, SM Alavian
Hepatitis Monthly 16 (4), 2016
742016
Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline
SM Alavian, B Hajarizadeh, KB Lankarani, H Sharafi, NE Daryani, S Merat, ...
Hepatitis Monthly 16 (8), 2016
602016
Development and validation of a simple, rapid and inexpensive PCR-RFLP method for genotyping of common IL28B polymorphisms: a useful pharmacogenetic tool for prediction of …
H Sharafi, A Pouryasin, SM Alavian, B Behnava, M Keshvari, ...
Hepatitis monthly 12 (3), 190, 2012
492012
The Distribution of Hepatitis C Virus Genotypes in Middle Eastern Countries: A Systematic Review and Meta-Analysis
H Ghaderi-Zefrehi, M Gholami-Fesharaki, H Sharafi, F Sadeghi, ...
Hepatitis Monthly 16 (9), 2016
482016
Distribution of IL28B genotypes in Iranian patients with chronic hepatitis C and healthy individuals
H Sharafi, A Pouryasin, SM Alavian, B Behnava, M Keshvari, S Salimi, ...
Hepatitis monthly 12 (12), 2012
382012
Hepatitis A Virus and Hepatitis E Virus Seroprevalence Among Blood Donors in Tehran, Iran
K Hesamizadeh, H Sharafi, H Keyvani, SM Alavian, ANT Shabankareh, ...
Hepatitis Monthly 16 (1), 2016
282016
Prevalence and trends of transfusion-transmitted infections among blood donors in Tehran, Iran from 2008 to 2013
M Keshvari, H Sharafi, SM Alavian, H Mehrabadi, S Zolfaghari
Transfusion and Apheresis Science 53 (1), 38-47, 2015
272015
Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patients
A Haj-sheykholeslami, M Keshvari, H Sharafi, A Pouryasin, K Hemmati, ...
World journal of gastroenterology: WJG 21 (29), 8935, 2015
272015
Association of-24CT, 1249GA, and 3972CT ABCC2 gene polymorphisms with methotrexate serum levels and toxic side effects in children with acute lymphoblastic leukemia
MJ Sharifi, G Bahoush, F Zaker, S Ansari, KA Rafsanjani, H Sharafi
Pediatric Hematology-Oncology 31 (2), 169-177, 2014
272014
IL28B polymorphism, Explanation for Different Responses to Therapy in Hepatitis C Patients
H Sharafi, SM Alavian
Hepatitis Monthly 11 (12), 958, 2011
252011
Combination of sofosbuvir, pegylated-interferon and ribavirin for treatment of hepatitis C virus genotype 1 infection: a systematic review and meta-analysis
F Dolatimehr, H Karimi-Sari, MS Rezaee-Zavareh, SM Alavian, ...
DARU Journal of Pharmaceutical Sciences 25 (1), 11, 2017
242017
The Impact of IFNL4 rs12979860 Polymorphism on Spontaneous Clearance of Hepatitis C; A Case-Control Study
H Sharafi, SM Alavian, B Behnava, A Pouryasin, M Keshvari
Hepatitis monthly 14 (10), 2014
242014
The Role of Polymorphisms Near the IL28B Gene on Response to Peg-Interferon and Ribavirin in Thalassemic Patients With Hepatitis C
B Behnava, H Sharafi, M Keshvari, A Pouryasin, L Mehrnoush, S Salimi, ...
Hepatitis Monthly 16 (1), 2016
232016
Combination of Ledipasvir and Sofosbuvir for treatment of hepatitis C virus genotype 1 infection: systematic review and meta-analysis
MS Rezaee-Zavareh, K Hesamizadeh, B Behnava, SM Alavian, ...
Annals of hepatology 16 (2), 188-197, 2017
212017
Update on Recommendations for the Clinical Management of Hepatitis C in Iran 2017
SM Alavian, H Sharafi
Hepatitis Monthly 17 (11), 2017
182017
Impact of IFNL4 rs12979860 and rs8099917 polymorphisms on response to Peg‐Interferon‐α and Ribavirin in patients with congenital bleeding disorder and …
M Keshvari, SM Alavian, B Behnava, A Pouryasin, JC Craig, H Sharafi
Journal of clinical laboratory analysis 31 (4), e22063, 2017
172017
Comparison of Serum Hepatitis B Virus DNA and HBsAg Levels Between HBeAg-Negative and HBeAg-Positive Chronic Hepatitis B Patients
M Keshvari, SM Alavian, H Sharafi
Jundishapur Journal of Microbiology 8 (3), 2015
172015
Efficacy of Prolonged Treatment With Pegylated Interferon (Peg-IFN) and Ribavirin in Thalassemic Patients With Hepatitis C Who Relapsed After Previous Peg-IFN-Based Therapy
S Sandoughdaran, SM Alavian, H Sharafi, B Behnava, S Salimi, ...
Hepatitis monthly 15 (1), 2015
162015
Seroepidemiology and clinical features of hepatitis delta among HBsAg carriers: a study from Hepatitis Clinic of Iranian Blood Transfusion Organization
M Keshvari, SM Alavian, B Aghaee, B Behnava, M Mahdavi, ...
Transfusion Medicine 24 (6), 411-417, 2014
162014
Mysterious Linkages Between Hepatitis C Virus Genotypes, Interleukin-28B Genotypes and Viral Clearance-A Meta-Analysis
SH Aalaei-Andabili, B Behnava, S Salimi, H Sharafi, SM Alavian
Hepatitis monthly 14 (3), 2014
152014
The system can't perform the operation now. Try again later.
Articles 1–20